Optum

Healthier Capital Founder and Former One Medical CEO Endorses Medeloop Amid Launch of New AI Research Agent

Retrieved on: 
Lundi, mai 6, 2024

Rubin's board appointment is complemented by an investment in Medeloop from Healthier Capital, the venture capital firm he founded to partner with technology-powered healthcare innovators.

Key Points: 
  • Rubin's board appointment is complemented by an investment in Medeloop from Healthier Capital, the venture capital firm he founded to partner with technology-powered healthcare innovators.
  • This announcement aligns with the debut of Medeloop's new AI Research Agent, which the team has named ART.
  • Building on its robust platform, Medeloop has launched ART, an autonomous research agent poised to transform clinical research workflows with minimal human oversight.
  • "We are thrilled to welcome Amir Dan Rubin from Healthier Capital to Medeloop's board of directors," said CEO, Rene Caissie at Medeloop.

P3 Health Partners Names Dr. Aric Coffman as CEO

Retrieved on: 
Mercredi, mai 8, 2024

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), today named Dr. Aric Coffman as P3’s Chief Executive Officer, effective as of May 8, 2024, succeeding Dr. Sherif Abdou, P3’s Co-Founder.

Key Points: 
  • P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), today named Dr. Aric Coffman as P3’s Chief Executive Officer, effective as of May 8, 2024, succeeding Dr. Sherif Abdou, P3’s Co-Founder.
  • Dr. Abdou will continue to serve as a Strategic Advisor to P3, and a member of the Company’s Board of Directors working closely with Dr. Coffman to ensure a smooth transition.
  • “I am extremely proud of and grateful to the team we have built at P3 Health Partners.
  • I would also like to thank Dr. Abdou for his excellent service as CEO since 2017 and look forward to our continued work together on behalf of P3.”
    About P3 Health Partners (NASDAQ: PIII):
    P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by improving the lives of both patients and providers.

PracticeTek Appoints Steve Auerbach as New Chief Executive Officer

Retrieved on: 
Mardi, mai 7, 2024

PracticeTek, a leading provider of software, payments and billing solutions to the retail healthcare market, has announced that Steve Auerbach has been named Chief Executive Officer, effective May 1, 2024.

Key Points: 
  • PracticeTek, a leading provider of software, payments and billing solutions to the retail healthcare market, has announced that Steve Auerbach has been named Chief Executive Officer, effective May 1, 2024.
  • “I am thrilled to accept the role as Chief Executive Officer of PracticeTek,” said Steve Auerbach.
  • I look forward to working closely with the PracticeTek team to create an industry-leading platform for our customers.”
    “We are excited to have Steve join PracticeTek as Chief Executive Officer,” said Michal Petrzela, Managing Director at Lightyear Capital, which owns majority stake in the Company.
  • We are pleased to welcome Steve and are confident that his experience will enable him to build off PracticeTek’s strong foundation to significantly grow the company.”

CLn Skin Care Expands Medical Advisory Board

Retrieved on: 
Mardi, mai 7, 2024

DALLAS, May 7, 2024 /PRNewswire/ -- CLn Skin Care, the innovative brand known for its breakthrough line of gentle yet effective cleansers for the face and body, today announces the appointment of two distinguished physician leaders to its esteemed medical advisory board (MAB) of the company: Shakha Gillin, MD, FAAP, and Doug Krohn, MD, FAAP. Adding the new Pediatric Medicine specialists to CLn's medical advisory board further reinforces the brand's commitment to advancing skin health for all ages through diverse expertise and insights.

Key Points: 
  • Adding the new Pediatric Medicine specialists to CLn's medical advisory board further reinforces the brand's commitment to advancing skin health for all ages through diverse expertise and insights.
  • CLn Skin Care appoints two physician leaders to its medical board: Shakha Gillin, MD, FAAP, and Doug Krohn, MD, FAAP.
  • Shakha Gillin, MD, FAAP, brings a wealth of experience in pediatric medicine and preventative care to CLn Skin Care.
  • Dr. Doug Krohn, a distinguished primary care pediatrician and specialist in neonatal care and cognitive behavior therapy, adds a unique perspective to CLn Skin Care's board of directors.

Andromeda Partners with Optum to Transform Healthcare User-Insurance Experience

Retrieved on: 
Jeudi, avril 25, 2024

The initiative aims to boost interoperability between payers and providers and improve patient experiences with healthcare technologies across the US.

Key Points: 
  • The initiative aims to boost interoperability between payers and providers and improve patient experiences with healthcare technologies across the US.
  • Insurance eligibility verification is essential for accessing medical services and ensuring healthcare providers are paid.
  • Andromeda acknowledges this burden and teams up with Optum to utilize its extensive healthcare insurance insights and top-tier healthcare solutions to address a critical point of healthcare delivery-insurance eligibility verification.
  • Andromeda's and Optum's work exemplifies just one facet of its broader features, facilitating a holistic and efficient healthcare technology experience.

Blue Cross and Blue Shield of Minnesota Announces Chris Boles as Vice President of Medicare, Melissa Flicek as Chief Information Officer

Retrieved on: 
Mardi, avril 23, 2024

Chris Boles has joined the organization as vice president of Medicare and Individual segments, while Melissa Flicek will serve as chief information officer.

Key Points: 
  • Chris Boles has joined the organization as vice president of Medicare and Individual segments, while Melissa Flicek will serve as chief information officer.
  • “Chris Boles and Melissa Flicek both bring impressive experience and proven results from their respective fields,” said Dana Erickson, president and CEO of Blue Cross and Blue Shield of Minnesota.
  • Boles has held multiple leadership roles at Elevance Health, including vice president of Group Retiree Solutions and regional vice president of Medicare Blue Alliances.
  • Melissa Flicek – Vice President, Chief Information Officer
    Flicek has more than 20 years of experience in leading technology development and business transformation strategies.

Nym Welcomes Benjamin Gold as Senior Vice President of Product

Retrieved on: 
Jeudi, avril 25, 2024

Nym, the leader in autonomous medical coding, today announced that Benjamin Gold has joined the Company’s executive leadership team as Senior Vice President of Product.

Key Points: 
  • Nym, the leader in autonomous medical coding, today announced that Benjamin Gold has joined the Company’s executive leadership team as Senior Vice President of Product.
  • Gold joins Nym during an exciting period of growth, with the Company recently expanding its autonomous coding solution’s capabilities to support new specialty areas such as outpatient surgery and inpatient professional services .
  • In his role as SVP of Product, Gold will lead the Company’s product strategy and development, focusing on deploying new coding specialties, scaling Nym’s delivery capabilities, and exploring additional opportunities in the payer market.
  • “I’m delighted to join the Nym team and to be part of a cutting-edge company on the forefront of innovation in healthcare revenue cycle management,” said Gold.

UnitedHealth Group Reports First Quarter 2024 Results

Retrieved on: 
Mardi, avril 16, 2024

UnitedHealth Group’s first quarter 2024 revenues grew nearly $8 billion year over year to $99.8 billion.

Key Points: 
  • UnitedHealth Group’s first quarter 2024 revenues grew nearly $8 billion year over year to $99.8 billion.
  • Days claims payable of 47.1 compared to 47.9 in fourth quarter 2023 and 47.8 in first quarter 2023.
  • The first quarter 2024 medical care ratio at 84.3% included 40 basis points of impact due to accommodations to support care providers.
  • The first quarter 2024 operating cost ratio of 14.1% included approximately 30 basis points of impact due to costs incurred to support the company’s direct response efforts.

Aspirion Appoints Tina Eller to Newly Created Role of Chief Experience Officer

Retrieved on: 
Mardi, avril 9, 2024

COLUMBUS, Ga., April 9, 2024 /PRNewswire/ -- Aspirion, a leading technology-enabled healthcare revenue cycle management ("RCM") provider for revenue integrity and complex claims, announced today that Tina Eller has been appointed to the new position of Chief Experience Officer, effective immediately.

Key Points: 
  • COLUMBUS, Ga., April 9, 2024 /PRNewswire/ -- Aspirion, a leading technology-enabled healthcare revenue cycle management ("RCM") provider for revenue integrity and complex claims, announced today that Tina Eller has been appointed to the new position of Chief Experience Officer, effective immediately.
  • The creation of this executive position and Eller's appointment underscores Aspirion's deep commitment to exceptional results and client focus.
  • With over 25 years of revenue cycle experience, Eller brings a wealth of expertise to Aspirion.
  • During the initial half of her career, Eller held various Revenue Cycle Management roles with Centura Health.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UnitedHealth Group Incorporated - UNH

Retrieved on: 
Samedi, mars 23, 2024

NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH).

Key Points: 
  • NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH).
  • 7980
    The investigation concerns whether UnitedHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On February 27, 2024, The Wall Street Journal (“WSJ”) reported that the U.S. Department of Justice (“DOJ”) has launched an antitrust investigation into UnitedHealth.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.